High-Purity Building Blocks…Crafted for Performance. Ready for Scale.
Overview
Sapala Organics offers a portfolio of high-purity oligonucleotide building blocks that power next-generation therapeutics and diagnostics. Our range—spanning Phosphoramidites, NTPs, CAP reagents, GalNAc conjugates, and fluorescent dyes—is engineered for consistency and manufactured under stringent quality control at scale.
Why Choose Cohance + Sapala for Oligo Building Blocks?
Why Choose Cohance + Sapala for Oligo Building Blocks?
- Trusted supplier to global biopharma companies for early and late-phase needs
- Consistent delivery at both R&D and GMP-grade scales
- Rapid support for custom synthesis
- Backed by integrated development and manufacturing
Manufacturing Strengths
Manufacturing Strengths
Scalable Production: Flexible volumes from gram to multi-ton capacity across multiple sites.
GMP-Ready Infrastructure: USFDA-, EMA-, and PMDA-approved sites with validated processes and full traceability.
Technology-Enabled Execution: Flow reactors, high-pressure systems (up to 20 kg/cm²), cryogenic capabilities (-70°C), and automation.
Regulatory Compliance: 200+ DMFs filed globally; extensive experience in audits and global market readiness.
Lifecycle Manufacturing: Support for reprocessing, impurity purge, solvent recovery, and green manufacturing practices.
Product Categories
Scalable
Production
Flexible volumes from gram to multi-ton capacity across multiple sites.
GMP-Ready
Infrastructure
USFDA-, EMA-, and PMDA-approved sites with validated processes and full traceability.
Technology-Enabled
Execution
Flow reactors, high-pressure systems (up to 20 kg/cm²), cryogenic capabilities (-70°C), and automation.
Regulatory
Compliance
200+ DMFs filed globally; extensive experience in audits and global market readiness.
Lifecycle
Manufacturing
Support for reprocessing, impurity purge, solvent recovery, and green manufacturing practices.
Nucleoside and
Phosphoramidite Derivatives
Wide range of modified amidites and nucleosides, including locked/bridged nucleic acids, FANA, oxime compounds, morpholino compounds, and diastereotopically pure amidites. Excellent impurity control (≤0.2%–0.3%). Among the few globally supplying multi-kg tri-cyclo DNA.
Linkers
and Spacers
Custom-designed chemical linkers and spacers that enhance the conjugation of oligonucleotides with targeting or delivery molecules, improving therapeutic stability and efficacy.
PEG Derivatives
GalNAc Conjugates
Sugar derivatives, lipids, and PEG-based linkers developed for targeted oligonucleotide delivery. Multi-kg scale GalNAc synthesis for clinical-stage biopharma partners.
mRNA
Building Blocks
Supply of modified NTPs and chemically synthesized N1-Me-pseudouridine at multi-kilo scale. Includes cap reagents for mRNA vaccines and therapies.
Fluorescent
Dyes
Large-scale synthesis of 6-FAM, TET, Cy3, TAMRA, Cy5, and other dyes used in molecular diagnostics, gene sequencing, and imaging platforms.
Nucleoside and
Phosphoramidite Derivatives
Wide range of modified amidites and nucleosides, including locked/bridged nucleic acids, FANA, oxime compounds, morpholino compounds, and diastereotopically pure amidites. Excellent impurity control (≤0.2%–0.3%). Among the few globally supplying multi-kg tri-cyclo DNA.
Linkers
and Spacers
Custom-designed chemical linkers and spacers that enhance the conjugation of oligonucleotides with targeting or delivery molecules, improving therapeutic stability and efficacy.
PEG Derivatives
GalNAc Conjugates
Sugar derivatives, lipids, and PEG-based linkers developed for targeted oligonucleotide delivery. Multi-kg scale GalNAc synthesis for clinical-stage biopharma partners.
mRNA
Building Blocks
Supply of modified NTPs and chemically synthesized N1-Me-pseudouridine at multi-kilo scale. Includes cap reagents for mRNA vaccines and therapies.
Fluorescent
Dyes
Large-scale synthesis of 6-FAM, TET, Cy3, TAMRA, Cy5, and other dyes used in molecular diagnostics, gene sequencing, and imaging platforms.
Facilities
Genome Valley R&D Center: 25,000 sq. ft. of dedicated process development and safety labs.
Commercial Manufacturing Sites: Multi-ton capacity, including facilities for HPAPIs, phosphoramidites, and other complex chemistries.
Flow Chemistry Suites: Plug flow reactors, Corning G1 systems, and photo flow platforms.
Integrated Development Services
Early Phase Development
Lab-scale feasibility, synthetic optimization, and impurity identification.
Scale-Up Readiness
Execution of engineering and validation batches using advanced reactors and process tools.
Lifecycle Services
Rework/reprocessing studies, solvent recovery, impurity fate, and purge investigations.
Special Capabilities
Expertise in hazardous reactions, air-/moisture-sensitive chemistries, stereoselective synthesis, and green catalysis.
Genome Valley R&D Center
25,000 sq. ft. of dedicated process development and safety labs.
Commercial Manufacturing Sites
Multi-ton capacity, including facilities for HPAPIs, phosphoramidites, and other complex chemistries.
Flow Chemistry Suites
Plug flow reactors, Corning G1 systems, and photo flow platforms.
Facilities
We operate a robust network of cutting-edge small molecule development and manufacturing facilities across India. Our infrastructure spans lab-scale discovery to large-scale commercial manufacturing — enabling faster, flexible, and scalable solutions for your drug development needs.
Genome Valley R&D Center
25,000 sq. ft. of dedicated process development and safety labs.
Commercial Manufacturing Sites
Multi-ton capacity, including facilities for HPAPIs, phosphoramidites, and other complex chemistries.
Flow Chemistry Suites
Plug flow reactors, Corning G1 systems, and photo flow platforms.
Our early-stage R&D and kilo labs are designed to support route scouting, process development, and scale-up studies.
Designed to seamlessly scale from clinical to commercial manufacturing, these facilities are compliant with global regulatory standards including the US FDA.
Genome Valley R&D Center
25,000 sq. ft. of dedicated process development and safety labs.
Commercial Manufacturing Sites
Multi-ton capacity, including facilities for HPAPIs, phosphoramidites, and other complex chemistries.
Flow Chemistry Suites
Plug flow reactors, Corning G1 systems, and photo flow platforms.
From grams to tons-trust Cohance to deliver your small molecule at scale.
Contact Manufacturing Team
Looking for high-purity building blocks tailored to your oligonucleotide platform?
Contact UsResources
- Webinar: De-Risking Early-Phase API Development
- Case Study: Accelerated Scale-Up of a Chiral Intermediate
- Whitepaper: Green Chemistry in Route Optimization
- Blog: The Role of Analytical Precision in Small Molecule Success
Resource Highlights
Webinars
Navigating Regulatory Audits in Small Molecule Manufacturing
Whitepapers
Smart Scale-Up Using Flow Chemistry
Case Studies
Seamless Tech Transfer of a Multi-Step Synthesis
Blog
Building Sustainable API Supply Chains
Webinars
Navigating Regulatory Audits in Small Molecule Manufacturing
Whitepapers
Smart Scale-Up Using Flow Chemistry
Case Studies
Seamless Tech Transfer of a Multi-Step Synthesis
Blog
Building Sustainable API Supply Chains
Our Global Accreditations
At Cohance Lifesciences, every facility stands as a testament to our commitment to uncompromised quality. Below is a snapshot of regulatory approvals and certifications across our global network
API Manufacturing Facilities
API Unit I
• US FDA, EU, PMDA, Russia MOH, KFDA, COFEPRIS, CDSCO, DCA, WHO GMP
API Unit II
• EU, DCA
API Unit III
• US FDA, EDQM, PMDA, KFDA, ANVISA, COFEPRIS, CDSCO, DCA
API Unit IV
• US FDA, EU, CDSCO, DCA
API Unit V
• ISO, DCA
Formulation (FDF) Facilities
FDF Unit I
• US FDA, Health Canada, MHRA, ANVISA, COFEPRIS, Russia MOH, TGA, Philippines FDA, Tanzania FDA, Greece NOM, Uganda NDA, Germany, SFDA, CDSCO, DCA
FDF Unit II
• CDSCO, DCA
Clinical Research
CR Bio
• US FDA, DCGI, MOH Turkey, BPFK Malaysia, WHO Geneva, MHRA, GCC, NPRA Malaysia
Suven Pharma Sites
Unit 1 to Unit 4, and Unit 6
• British Safety Council, International Safety
• ISO 20400:2017, ISO 22301:2019, ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 50001:2018
Unit 5
• US FDA, DCA, PPD Global Quality Compliance, EU, CDSCO
• ISO 22301:2019, ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 50001:2018
Casper
• US FDA, DCA
Our ESG Aspirations
Cohance is committed to a sustainable future with ambitious goals:
- Net-Zero Emissions by 2050: Focusing on decarbonization, renewable energy, and resource efficiency, aligned with Science-Based Targets (SBTi).
- Environmental Sustainability: Enhancing green practices through sustainable procurement and biodiversity protection.
- Social Impact: Expanding community engagement in health, sanitation, and water access, while supporting economic development through CSR initiatives.
- UN SDG Alignment: Contributing to goals like Good Health and Well-Being, Clean Water and Sanitation, and Responsible Consumption and Production.
- Ethical Governance: Strengthening transparency, ethics, and responsible sourcing through global initiatives like the Pharmaceutical Supply Chain Initiative (PSCI).
At Cohance, ESG is our promise to go above and beyond, shaping a sustainable future for health science through passion, expertise, and unwavering responsibility.
History
Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet
Lorem ipsum
Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet
Experience
Our great team of more than 1400 software experts.
Quick Support
We’ll help you test bold new ideas while sharing your.
Leadership Team
John Smith
CEO
Emma London
Co-Founder
Jessica Brown
Managing Director
Christine Eve
Designer
Sustainability
ESG
Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet
EHS
Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet
Quality & Compliance
Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet
We deal With The Aspects Of Professional IT Services
About usEngitech is the partner of choice for many of the world’s leading enterprises, SMEs and technology challengers. We help businesses elevate their value through custom software development, product design,
Experience
Our great team of more than 1400 software experts.
Quick Support
We’ll help you test bold new ideas while sharing your.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna.
440
employees from around the world
+
640
happy clients from largest corporations
+
0
offices in 6 counties worldwide
We deal With The Aspects Of Professional IT Services
About usEngitech is the partner of choice for many of the world’s leading enterprises, SMEs and technology challengers. We help businesses elevate their value through custom software development, product design,
UI/UX Design
95%
App Development
82%
Business Growth
90%
Technology Solution
80%
Science & Technology
Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet Lorem ipsum dolor sit amet
John Smith
A leading Company
Here’s What’s Happening
From our blog
